November 17, 2010 - Results from the GRAVITAS Trial found that doubling the maintenance dose of clopidogrel ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
November 16, 2010 โ Results from the ROCKET AF trial showed that rivaroxaban given once daily is superior at ...
November 8, 2010 โ The American College of Cardiology (ACC) and American Heart Association (AHA) issued a joint ...
October 25, 2010 - A post-hoc-analysis from JUPITER, published in the European Heart Journal, shows rosuvastatin ...
October 25, 2010 โ A new study shows that an intensive population management program that matches heart disease ...
October 20, 2010 - The U.S. Food and Drug Administration (FDA) approved a new drug to help prevent stroke and ...
October 15, 2010 โ The U.S. Food and Drug Administration (FDA) has approved an abbreviated new drug application ...
October 13, 2010 โ A recall was issued for bottles of 40 mg Lipitor, due to a small number of reports of an ...
October 13, 2010 โ The anti-obesity drug sibutramine will be withdrawn from the U.S. market after a study found it ...
October 8, 2010 โ New data from the HORIZONS-AMI trial shows that administering the anticoagulant bivalirudin ...
October 7, 2010 - Taking medication at night instead of in the morning significantly increases efficacy in ...
October 4, 2010 โ The U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee ...
September 24, 2010 - Trial data have established the safety of a reversible PAR-1 thrombin receptor antagonist in ...
A new class of antiplatelet therapy drug pending U.S. Food and Drug Administration (FDA) clearance may offer ...
September 15, 2010 โ A study evaluating the level of platelet aggregation achieved after switching from ...